TDOC
Teladoc Health, Inc.
$7.34
+0.41%
$1.3B
No data for this timeframe.
Vol
Market Cap$1.3B
Cap SizeSmall Cap
Analyst ConsensusHold (36%)
Inst. Holders50 funds
Inst. Value$552.1M
Inst. Activity25 buys / 13 sells
Insider Activity0B / 14S
Insider Net $-$1.2M
Reddit Sentiment50° Neutral
SEC Reports10
Press Releases1
Exchange NYSE·Sector Services-Offices & Clinics of Doctors of Medicine·Inc. DE·CIK 0001477449·Prev Close $7.31
Recent Activity
Jun 11, 2026
SEC
Charles Divita III, an officer and director of Teladoc Health, filed a Form 144 notice of intent to sell 18,074 shares o
144 — Impact 2/10
Jun 11, 2026
SEC
Three major institutional investors (Fidelity, Morgan Stanley, Citadel) added to Teladoc Health positions in Q3 2025, wh
INST-CLUSTER — Impact 3/10
Jun 3, 2026
Insider
Rodrigues Fernando M. sold 9,572 shares
President of BetterHelp @ $7.40 ($70.8K)
Jun 2, 2026
SEC
Charles Divita III, a director of Teladoc Health, filed a Form 144 notice of intent to sell 19,132 shares of common stoc
144 — Impact 2/10
Jun 2, 2026
Insider
Catapano Joseph Ronald sold 284 shares
Chief Accounting Officer @ $7.63 ($2.2K)
Jun 2, 2026
Insider
Bliss Kelly sold 7,679 shares
President, U.S. Group Health @ $7.63 ($58.6K)
Inst.
Point72 Asset Management, L.P. — ADD
7,721,495 shares ($42.1M)
Inst.
Allianz Asset Management GmbH — ADD
4,791,363 shares ($26.1M)
Price Targets
$7.30
-0.5% upside
Hold
Current $7.34
Low $5.00
Median $7.00
High $10.00
20 analysts
$5.00
$10.00
Analyst Ratings
4Strong Buy
8Buy
21Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 5, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
| Apr 8, 2026 | Evercore ISI Group | MAINTAIN | In-Line → In-Line |
| Mar 26, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Mar 13, 2026 | JP Morgan | MAINTAIN | Neutral → Neutral |
| Mar 10, 2026 | Deutsche Bank | UPGRADE | Hold → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.24 | $-0.24 — $-0.23 | -61% YoY | 3 |
| Next Q | $-0.17 | $-0.20 — $-0.16 | 8% YoY | 3 |
| Current FY | $-0.79 | $-0.89 — $-0.61 | -20% YoY | 4 |
| Next FY | $-0.65 | $-0.78 — $-0.55 | 18% YoY | 4 |
Latest Reports
NEUTRAL
144
2/10
Charles Divita III, an officer and director of Teladoc Health, filed a Form 144 notice of intent to sell 18,074 shares o
Jun 11, 2026
NEUTRAL
INST-CLUSTER
3/10
Three major institutional investors (Fidelity, Morgan Stanley, Citadel) added to Teladoc Health positions in Q3 2025, wh
Jun 11, 2026
NEUTRAL
Press
3/10
Teladoc Health appointed Susan Salka, former CEO of AMN Healthcare, to its board of directors, effective immediately. Th
Mar 30, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $79.6M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $67.0M | — |
| RENAISSANCE TECHNOLOGIES LLC | $44.1M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $42.8M | — |
| Point72 Asset Management, L.P. | $42.1M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 3, 2026 | Rodrigues Fernando | SELL | $70.8K |
| Jun 2, 2026 | Catapano Joseph | SELL | $2.2K |
| Jun 2, 2026 | Bliss Kelly | SELL | $58.6K |
| Jun 2, 2026 | Rodrigues Fernando | SELL | $43.3K |
| Jun 2, 2026 | DIVITA CHARLES | SELL | $145.9K |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
50 institutional holders with $552.1M total value (101,121,769 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, RENAISSANCE. Net buying activity: 25 institutions added/increased vs 13 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 14,613,556 | $79.6M | 14.4% | — |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 12,295,094 | $67.0M | 12.1% | — |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 8,085,542 | $44.1M | 8.0% | — |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 7,857,169 | $42.8M | 7.8% | — |
| 5 | Point72 Asset Management, L.P. | 7,721,495 | $42.1M | 7.6% | ADD +36.4% |
| 6 | DIMENSIONAL FUND ADVISORS LP | 6,298,405 | $34.3M | 6.2% | — |
| 7 | Allianz Asset Management GmbH | 4,791,363 | $26.1M | 4.7% | ADD +53.8% |
| 8 | STATE STREET CORP | 4,359,751 | $23.8M | 4.3% | — |
| 9 | JUPITER ASSET MANAGEMENT LTD | 3,109,714 | $16.9M | 3.1% | DOUBLED +293.9% |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3,037,974 | $16.6M | 3.0% | — |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,817,200 | $15.4M | 2.8% | — |
| 12 | GOLDMAN SACHS GROUP INC | 2,706,335 | $14.7M | 2.7% | — |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,822,600 | $9.9M | 1.8% | — |
| 14 | AMERIPRISE FINANCIAL INC | 1,815,930 | $9.9M | 1.8% | TRIM -33.6% |
| 15 | FEDERATED HERMES, INC. | 1,704,526 | $9.3M | 1.7% | DOUBLED +371.0% |
| 16 | BANK OF AMERICA CORP /DE/ | 1,595,219 | $8.7M | 1.6% | DOUBLED +289.9% |
| 17 | Freestone Grove Partners LP | 1,509,954 | $8.2M | 1.5% | — |
| 18 | MORGAN STANLEY | 1,338,643 | $7.3M | 1.3% | TRIM -53.5% |
| 19 | VANGUARD FIDUCIARY TRUST CO | 1,167,066 | $6.4M | 1.2% | — |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 885,526 | $4.8M | 0.9% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | ADD | 5,661,322 | 7,721,495 | +36.4% | $42.1M | 2026-Q1 |
| Allianz Asset Management GmbH | ADD | 3,115,191 | 4,791,363 | +53.8% | $26.1M | 2026-Q1 |
| FEDERATED HERMES, INC. | DOUBLED | 361,921 | 1,704,526 | +371.0% | $9.3M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 409,177 | 1,595,219 | +289.9% | $8.7M | 2026-Q1 |
| Trexquant Investment LP | TRIM | 1,307,952 | 854,116 | -34.7% | $4.7M | 2026-Q1 |
| FRANKLIN RESOURCES INC | ADD | 466,494 | 627,417 | +34.5% | $3.4M | 2026-Q1 |
| Nuveen, LLC | NEAR_EXIT | 2,659,662 | 524,002 | -80.3% | $2.9M | 2026-Q1 |
| MARSHALL WACE, LLP | DOUBLED | 61,924 | 419,574 | +577.6% | $2.3M | 2026-Q1 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | DOUBLED | 83,774 | 374,088 | +346.5% | $2.0M | 2026-Q1 |
| FIRST TRUST ADVISORS LP | ADD | 214,497 | 350,017 | +63.2% | $1.9M | 2026-Q1 |
| Mitsubishi UFJ Trust & Banking Corp | ADD | 159,788 | 256,664 | +60.6% | $1.4M | 2026-Q1 |
| Brevan Howard Capital Management LP | DOUBLED | 82,562 | 243,979 | +195.5% | $1.3M | 2026-Q1 |
| GROUP ONE TRADING LLC | ADD | 152,199 | 212,759 | +39.8% | $1.2M | 2026-Q1 |
| MACKENZIE FINANCIAL CORP | ADD | 165,550 | 208,692 | +26.1% | $1.1M | 2026-Q1 |
| JENNISON ASSOCIATES LLC | ADD | 100,360 | 158,832 | +58.3% | $865.6K | 2026-Q1 |
| BANCO BILBAO VIZCAYA ARGENTARIA, S.A. | TRIM | 136,821 | 93,296 | -31.8% | $479.5K | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | 58,370 | 86,638 | +48.4% | $472.2K | 2026-Q1 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | DOUBLED | 18,173 | 55,835 | +207.2% | $294.3K | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | 79,995 | 48,014 | -40.0% | $261.7K | 2026-Q1 |
| NOMURA HOLDINGS INC | ADD | 35,107 | 45,477 | +29.5% | $247.8K | 2026-Q1 |
| CWM, LLC | DOUBLED | 5,887 | 41,207 | +600.0% | $224.6K | 2026-Q1 |
| Verition Fund Management LLC | NEAR_EXIT | 343,916 | 35,379 | -89.7% | $192.8K | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | NEAR_EXIT | 342,100 | 34,900 | -89.8% | $190.2K | 2026-Q1 |
| Pictet Asset Management Holding SA | ADD | 26,346 | 33,439 | +26.9% | $182.2K | 2026-Q1 |
| FMR LLC | NEAR_EXIT | 736,726 | 30,123 | -95.9% | $164.2K | 2026-Q1 |
13 unique insiders with 50 transactions. Net insider value: -$1.2M ($0.00 bought, $1.2M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Rodrigues Fernando M. | President of BetterHelp | SELL | 9,572 | $7.40 | $70.8K |
| Jun 2, 2026 | Catapano Joseph Ronald | Chief Accounting Officer | SELL | 284 | $7.63 | $2.2K |
| Jun 2, 2026 | Bliss Kelly | President, U.S. Group Health | SELL | 7,679 | $7.63 | $58.6K |
| Jun 2, 2026 | Rodrigues Fernando M. | President of BetterHelp | SELL | 5,677 | $7.63 | $43.3K |
| Jun 2, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | SELL | 19,132 | $7.63 | $145.9K |
| Jun 2, 2026 | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | SELL | 7,906 | $7.63 | $60.3K |
| Jun 2, 2026 | Nueno Carlos | President, International | SELL | 6,196 | $7.63 | $47.3K |
| Jun 1, 2026 | Catapano Joseph Ronald | Chief Accounting Officer | EXERCISE | 833 | — | — |
| Jun 1, 2026 | Bliss Kelly | President, U.S. Group Health | EXERCISE | 4,858 | — | — |
| Jun 1, 2026 | Catapano Joseph Ronald | Chief Accounting Officer | EXERCISE | 39 | — | — |
| Jun 1, 2026 | Bliss Kelly | President, U.S. Group Health | EXERCISE | 1,300 | — | — |
| Jun 1, 2026 | Rodrigues Fernando M. | President of BetterHelp | EXERCISE | 5,491 | — | — |
| Jun 1, 2026 | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | EXERCISE | 426 | — | — |
| Jun 1, 2026 | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | EXERCISE | 5,350 | — | — |
| Jun 1, 2026 | Nueno Carlos | President, International | EXERCISE | 4,556 | — | — |
| Jun 1, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | EXERCISE | 1,966 | — | — |
| Jun 1, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | EXERCISE | 42,276 | — | — |
| May 21, 2026 | Jacobson Catherine | Director | AWARD | 30,441 | — | — |
| May 21, 2026 | SHEDLARZ DAVID L | Director | AWARD | 30,441 | — | — |
| May 21, 2026 | Fenwick Sandra L | Director | AWARD | 30,441 | — | — |
| May 21, 2026 | Smith Mark Douglas | Director | AWARD | 30,441 | — | — |
| May 21, 2026 | SNOW DAVID B JR | Director | AWARD | 30,441 | — | — |
| May 21, 2026 | Paulus Kenneth H | Director | AWARD | 30,441 | — | — |
| May 20, 2026 | SHEDLARZ DAVID L | Director | EXERCISE | 29,986 | — | — |
| May 20, 2026 | SHEDLARZ DAVID L | Director | EXERCISE | 28,986 | — | — |
| May 20, 2026 | Jacobson Catherine | Director | EXERCISE | 28,986 | — | — |
| May 20, 2026 | SNOW DAVID B JR | Director | EXERCISE | 28,986 | — | — |
| Apr 2, 2026 | Catapano Joseph Ronald | Chief Accounting Officer | SELL | 675 | $5.11 | $3.5K |
| Apr 1, 2026 | Catapano Joseph Ronald | Chief Accounting Officer | EXERCISE | 2,083 | — | — |
| Mar 30, 2026 | SALKA SUSAN R | Director | AWARD | 48,638 | — | — |
| Mar 11, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | SELL | 27,731 | $5.49 | $152.2K |
| Mar 10, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | EXERCISE | 39,160 | — | — |
| Mar 10, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | AWARD | 43,703 | — | — |
| Mar 10, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | EXERCISE | 25,493 | — | — |
| Mar 2, 2026 | Nueno Carlos | President, International | SELL | 20,165 | $5.12 | $103.2K |
| Mar 2, 2026 | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | SELL | 27,083 | $5.12 | $138.6K |
| Mar 2, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | SELL | 50,145 | $5.12 | $256.6K |
| Mar 2, 2026 | Bliss Kelly | President, U.S. Group Health | SELL | 26,647 | $5.12 | $136.4K |
| Mar 2, 2026 | Catapano Joseph Ronald | Chief Accounting Officer | SELL | 1,333 | $5.12 | $6.8K |
| Mar 1, 2026 | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | AWARD | 181,661 | — | — |
| Mar 1, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | AWARD | 692,041 | — | — |
| Mar 1, 2026 | Nueno Carlos | President, International | AWARD | 173,010 | — | — |
| Mar 1, 2026 | Bliss Kelly | President, U.S. Group Health | AWARD | 181,661 | — | — |
| Mar 1, 2026 | Catapano Joseph Ronald | Chief Accounting Officer | AWARD | 15,000 | — | — |
| Feb 27, 2026 | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | EXERCISE | 4,418 | — | — |
| Feb 27, 2026 | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | EXERCISE | 1,510 | — | — |
| Feb 27, 2026 | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | AWARD | 5,107 | — | — |
| Feb 27, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | EXERCISE | 7,864 | — | — |
| Feb 27, 2026 | DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | AWARD | 23,591 | — | — |
| Feb 27, 2026 | Bliss Kelly | President, U.S. Group Health | EXERCISE | 1,186 | — | — |
10 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 1 mixed, 7 neutral. Avg impact: 3.7/10.
NEUTRAL
144
2/10
Charles Divita III, an officer and director of Teladoc Health, filed a Form 144 notice of intent to
Jun 11, 2026
NEUTRAL
INST-CLUSTER
3/10
Three major institutional investors (Fidelity, Morgan Stanley, Citadel) added to Teladoc Health posi
Jun 11, 2026
NEUTRAL
144
2/10
Charles Divita III, a director of Teladoc Health, filed a Form 144 notice of intent to sell 19,132 s
Jun 2, 2026
NEUTRAL
144
2/10
Adam Vandervoort, an officer of Teladoc Health, filed a Form 144 notice of intent to sell 7,906 shar
Jun 2, 2026
NEUTRAL
PRESS-RELEASE
3/10
Teladoc Health announced it will release Q1 2026 earnings on April 29, 2026, after market close, wit
Apr 15, 2026
NEUTRAL
DEFA14A
3/10
Teladoc Health is holding its 2026 annual meeting to elect nine directors, approve executive compens
Apr 7, 2026
NEUTRAL
3
2/10
Susan R. Salka, a reporting owner at Teladoc Health, filed a Form 3 to report her initial beneficial
Apr 1, 2026
BEARISH
CLUSTER
7/10
Multiple high-level executives at Teladoc Health, including CEO Charles Divita and other C-suite lea
Mar 3, 2026
BEARISH
CLUSTER
7/10
Three top executives at Teladoc Health — including CEO Charles Divita and the Chief Legal Officer —
Mar 3, 2026
MIXED
8-K
6/10
Teladoc Health reported flat Q4 revenue of $642.3 million (0% YoY) and full-year 2025 revenue down 2
Feb 26, 2026
Current analyst consensus: Sell (36% buy). Based on 33 analysts: 4 strong buy, 8 buy, 21 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$7.30 mean target
-0.5% upside
Hold (2.48)
$5.00 Low
$10.00 High
| Metric | Value |
|---|---|
| Current Price | $7.34 |
| Target Low | $5.00 |
| Target Mean | $7.30 |
| Target Median | $7.00 |
| Target High | $10.00 |
| # Analysts | 20 |
| Recommendation | Hold (2.48) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.24 | $-0.24 | $-0.23 | -60.7% | +0.0% | 0↑ 2↓ | $0.6B | -2.5% | 3 |
| Next Q 2026-09-30 |
$-0.17 | $-0.20 | $-0.16 | 7.7% | +0.0% | 1↑ 0↓ | $0.6B | 0.4% | 3 |
| Current FY 2026-12-31 |
$-0.79 | $-0.89 | $-0.61 | -20.0% | +0.0% | 2↑ 1↓ | $2.5B | -1.0% | 4 |
| Next FY 2027-12-31 |
$-0.65 | $-0.78 | $-0.55 | 17.8% | +0.0% | 2↑ 0↓ | $2.5B | 1.3% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.237 | |
| 7d ago | $-0.237 | |
| 30d ago | $-0.237 | |
| 60d ago | $-0.223 | -0.013 |
| 90d ago | $-0.223 | -0.013 |
13 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 5, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Apr 8, 2026 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Mar 26, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Mar 13, 2026 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Mar 10, 2026 | Deutsche Bank | UPGRADE | Hold | Buy |
| Mar 3, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Mar 3, 2026 | Oppenheimer | MAINTAIN | Outperform | Outperform |
| Feb 26, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | Leerink Partners | MAINTAIN | Market Perform | Market Perform |
| Feb 26, 2026 | TD Cowen | MAINTAIN | Hold | Hold |
| Feb 26, 2026 | BMO Capital | MAINTAIN | Market Perform | Market Perform |
| Feb 26, 2026 | Piper Sandler | REITERATE | Overweight | Overweight |
| Feb 26, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Feb 26, 2026 | Stifel | MAINTAIN | Hold | Hold |
| Jan 9, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 8 | 21 | 0 | 0 | 36% | |
| May 1, 2026 | 4 | 8 | 21 | 0 | 0 | 36% | |
| Apr 1, 2026 | 4 | 8 | 21 | 0 | 0 | 36% | |
| Mar 1, 2026 | 4 | 7 | 23 | 0 | 0 | 32% | |
| Feb 1, 2026 | 3 | 7 | 24 | 0 | 0 | 29% | |
| Jan 1, 2026 | 3 | 7 | 24 | 0 | 0 | 29% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
1 mentions
0 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Feb 27, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
May 22, 2026
short_volume
Short Volume: TDOC — 55.7% short (0.5M / 0.9M)
Short: 484,602 | Exempt: 949 | TRF Vol: 869,569 | Short Ratio: 55.7% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: TDOC — 63.1% short (0.7M / 1.2M)
Short: 741,953 | Exempt: 2,449 | TRF Vol: 1,175,236 | Short Ratio: 63.1% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: TDOC — 60.7% short (0.7M / 1.1M)
Short: 671,862 | Exempt: 2,435 | TRF Vol: 1,106,376 | Short Ratio: 60.7% | Off-exchange volume (dark pool + OTC)
May 5, 2026
short_volume
Short Volume: TDOC — 57.4% short (1.6M / 2.8M)
Short: 1,582,775 | Exempt: 17,664 | TRF Vol: 2,755,169 | Short Ratio: 57.4% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
earnings
Teladoc Health Reports First Quarter 2026 Results
<p align="left">NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported fi
Apr 29, 2026
short_volume
Short Volume: TDOC — 66.0% short (1.5M / 2.3M)
Short: 1,495,109 | Exempt: 14 | TRF Vol: 2,265,633 | Short Ratio: 66.0% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
earnings_calendar
TDOC Q1 2026 Earnings After Market Close — 2026-04-29
Apr 23, 2026
short_volume
Short Volume: TDOC — 55.9% short (1.2M / 2.2M)
Short: 1,218,008 | Exempt: 207 | TRF Vol: 2,177,378 | Short Ratio: 55.9% | Off-exchange volume (dark pool + OTC)
Apr 15, 2026
earnings
Teladoc Health to Announce First Quarter 2026 Financial Results
<p>NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release
Mar 31, 2026
short_volume
Short Volume: TDOC — 57.1% short (1.8M / 3.1M)
Short: 1,776,991 | Exempt: 4,893 | TRF Vol: 3,109,911 | Short Ratio: 57.1% | Off-exchange volume (dark pool + OTC)
Mar 30, 2026
leadership
Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
<p>NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of S
Mar 26, 2026
short_volume
Short Volume: TDOC — 78.9% short (1.7M / 2.2M)
Short: 1,743,233 | Exempt: 3,828 | TRF Vol: 2,210,285 | Short Ratio: 78.9% | Off-exchange volume (dark pool + OTC)
Mar 25, 2026
short_volume
Short Volume: TDOC — 67.2% short (1.3M / 1.9M)
Short: 1,293,961 | Exempt: 8,809 | TRF Vol: 1,924,156 | Short Ratio: 67.2% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
short_volume
Short Volume: TDOC — 56.0% short (1.0M / 1.9M)
Short: 1,036,832 | Exempt: 2,670 | TRF Vol: 1,850,517 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Mar 4, 2026
other
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
<p>NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued